My Quote Request
No products added yet
6505-01-340-4829
20 Products
NDC60505-0067-01
CLONAZEPAM TABLETS,USP
NSN, MFG P/N
6505013404829
NSN
6505-01-340-4829
NDC60505-0067-01
CLONAZEPAM TABLETS,USP
NSN, MFG P/N
6505013404829
NSN
6505-01-340-4829
MFG
FALCON PHARMACEUTICALS LTD
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS CLONAZEPAM ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLONAZEPAM TABLETS USP 1MG I.S. 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP, REVERSE NUMBERED
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SPECIAL FEATURES: UNIT DOSE; REVERSE NUMBER PACK
TOTAL PRIMARY CONTAINER QUANTITY: 4
Related Searches:
A91E006
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505013405444
NSN
6505-01-340-5444
A91E006
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505013405444
NSN
6505-01-340-5444
MFG
DEPARTMENT OF THE ARMY U S ARMY MEDICAL MATERIAL AGENCY MCMR-MMT-D
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.175 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVOTHYROXINE SODIUM TABLETS USP 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00048-1100-03
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505013405444
NSN
6505-01-340-5444
NDC00048-1100-03
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505013405444
NSN
6505-01-340-5444
MFG
KNOLL PHARMACEUTICALS A UNIT OF BASF K AND F CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.175 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVOTHYROXINE SODIUM TABLETS USP 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
SYNTHROID
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505013405444
NSN
6505-01-340-5444
SYNTHROID
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505013405444
NSN
6505-01-340-5444
MFG
BOOTS PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.175 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVOTHYROXINE SODIUM TABLETS USP 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
SYNTHROID TABLETS
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505013405444
NSN
6505-01-340-5444
SYNTHROID TABLETS
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505013405444
NSN
6505-01-340-5444
MFG
BOOTS PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.175 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVOTHYROXINE SODIUM TABLETS USP 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
F91E203
GUAIFENESIN EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505013405446
NSN
6505-01-340-5446
F91E203
GUAIFENESIN EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505013405446
NSN
6505-01-340-5446
MFG
AIR FORCE MEDICAL LOGISTICS OFFICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 600.000 MILLIGRAMS GUAIFENESIN ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GUAIFENESIN EXTENDED-RELEASE TABLETS 600MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SUSTAINED ACTING FOR 12 HOURS AFTER ADMINISTRATION
Related Searches:
HUMIBID L.A.
GUAIFENESIN EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505013405446
NSN
6505-01-340-5446
HUMIBID L.A.
GUAIFENESIN EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505013405446
NSN
6505-01-340-5446
MFG
UCB MANUFACTURING INC. DBA FOREIGN PARENT IS CELLTECH GROUP PLC SLOUGH ENGLAND.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 600.000 MILLIGRAMS GUAIFENESIN ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GUAIFENESIN EXTENDED-RELEASE TABLETS 600MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SUSTAINED ACTING FOR 12 HOURS AFTER ADMINISTRATION
Related Searches:
NDC53014-0012-50
GUAIFENESIN EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505013405446
NSN
6505-01-340-5446
NDC53014-0012-50
GUAIFENESIN EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505013405446
NSN
6505-01-340-5446
MFG
UCB MANUFACTURING INC. DBA FOREIGN PARENT IS CELLTECH GROUP PLC SLOUGH ENGLAND.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 600.000 MILLIGRAMS GUAIFENESIN ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GUAIFENESIN EXTENDED-RELEASE TABLETS 600MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SUSTAINED ACTING FOR 12 HOURS AFTER ADMINISTRATION
Related Searches:
08-4418
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013405447
NSN
6505-01-340-5447
08-4418
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013405447
NSN
6505-01-340-5447
MFG
NATIONAL MEDICAL CARE MEDICAL PRODUCTS DIV INC DBA ERIKA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 35.000 MILLIEQUIVALENTS BICARBONATE PER LITER AND 2.500 MILLIEQUIVALENTS CALCIUM PER LITER AND 104.250 MILLIEQUIVALENTS CHLORIDE PER LITER AND 2.000 GRAMS DEXTROSE PER LITER AND 0.750 MILLIEQUIVALENTS MAGNESIUM PER LITER AND 1.000 MILLIEQUIVALENTS
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,NATIONAL MEDICAL CARE
PRIMARY CONTAINER CONTENT QUANTITY: 3.430 LITERS OR 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: FOR USE W/COBE BICARBONATE PROPORTIONING SYSTEMS
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: POTASSIUM PER LITER AND 137.000 MILLIEQUIVALENTS SODIUM PER LITER AND 2.000 MILLIEQUIVALENTS ACETATE PER LIIER
Related Searches:
A91B005
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013405447
NSN
6505-01-340-5447
A91B005
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013405447
NSN
6505-01-340-5447
MFG
DEPARTMENT OF THE ARMY U S ARMY MEDICAL MATERIAL AGENCY MCMR-MMT-D
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 35.000 MILLIEQUIVALENTS BICARBONATE PER LITER AND 2.500 MILLIEQUIVALENTS CALCIUM PER LITER AND 104.250 MILLIEQUIVALENTS CHLORIDE PER LITER AND 2.000 GRAMS DEXTROSE PER LITER AND 0.750 MILLIEQUIVALENTS MAGNESIUM PER LITER AND 1.000 MILLIEQUIVALENTS
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,NATIONAL MEDICAL CARE
PRIMARY CONTAINER CONTENT QUANTITY: 3.430 LITERS OR 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: FOR USE W/COBE BICARBONATE PROPORTIONING SYSTEMS
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: POTASSIUM PER LITER AND 137.000 MILLIEQUIVALENTS SODIUM PER LITER AND 2.000 MILLIEQUIVALENTS ACETATE PER LIIER
Related Searches:
NATURALYTE
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013405447
NSN
6505-01-340-5447
NATURALYTE
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505013405447
NSN
6505-01-340-5447
MFG
NATIONAL MEDICAL CARE MEDICAL PRODUCTS DIV INC DBA ERIKA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 35.000 MILLIEQUIVALENTS BICARBONATE PER LITER AND 2.500 MILLIEQUIVALENTS CALCIUM PER LITER AND 104.250 MILLIEQUIVALENTS CHLORIDE PER LITER AND 2.000 GRAMS DEXTROSE PER LITER AND 0.750 MILLIEQUIVALENTS MAGNESIUM PER LITER AND 1.000 MILLIEQUIVALENTS
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,NATIONAL MEDICAL CARE
PRIMARY CONTAINER CONTENT QUANTITY: 3.430 LITERS OR 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: FOR USE W/COBE BICARBONATE PROPORTIONING SYSTEMS
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: POTASSIUM PER LITER AND 137.000 MILLIEQUIVALENTS SODIUM PER LITER AND 2.000 MILLIEQUIVALENTS ACETATE PER LIIER
Related Searches:
103401
TRIFLUOPERAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013406018
NSN
6505-01-340-6018
103401
TRIFLUOPERAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013406018
NSN
6505-01-340-6018
MFG
GOLDEN STATE MEDICAL SUPPLY INC. DBA GSMS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS TRIFLUOPERAZINE HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00781-1031-01
TRIFLUOPERAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013406018
NSN
6505-01-340-6018
NDC00781-1031-01
TRIFLUOPERAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013406018
NSN
6505-01-340-6018
MFG
GENEVA PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS TRIFLUOPERAZINE HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
A91D056
FILGRASTIM INJECTION
NSN, MFG P/N
6505013407974
NSN
6505-01-340-7974
MFG
DEPARTMENT OF THE ARMY U S ARMY MEDICAL MATERIAL AGENCY MCMR-MMT-D
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MICROGRAMS FILGRASTIM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NEUPOGEN
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC55513-0530-10
FILGRASTIM INJECTION
NSN, MFG P/N
6505013407974
NSN
6505-01-340-7974
NDC55513-0530-10
FILGRASTIM INJECTION
NSN, MFG P/N
6505013407974
NSN
6505-01-340-7974
MFG
AMGEN INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MICROGRAMS FILGRASTIM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NEUPOGEN
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NEUPOGEN
FILGRASTIM INJECTION
NSN, MFG P/N
6505013407974
NSN
6505-01-340-7974
MFG
AMGEN INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MICROGRAMS FILGRASTIM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NEUPOGEN
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
01290
FLUOROURACIL INJECTION,USP
NSN, MFG P/N
6505013408816
NSN
6505-01-340-8816
MFG
SOLOPAK MEDICAL PRODUCTS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS FLUOROURACIL PER MILLILITER
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: PHARMACY BULK VIAL; PRESERVATIVE-FREE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC39769-0012-90
FLUOROURACIL INJECTION,USP
NSN, MFG P/N
6505013408816
NSN
6505-01-340-8816
NDC39769-0012-90
FLUOROURACIL INJECTION,USP
NSN, MFG P/N
6505013408816
NSN
6505-01-340-8816
MFG
SOLOPAK MEDICAL PRODUCTS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS FLUOROURACIL PER MILLILITER
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: PHARMACY BULK VIAL; PRESERVATIVE-FREE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00024-1412-50
IOHEXOL INJECTION
NSN, MFG P/N
6505013408817
NSN
6505-01-340-8817
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 240.000 MILLIGRAMS IODINE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: PRESERVATIVE FREE
TOTAL PRIMARY CONTAINER QUANTITY: 10
UNIT PACKAGE TYPE: PACKAGE
Related Searches:
GLUTOSE
GLUCOSE GEL
NSN, MFG P/N
6505013408818
NSN
6505-01-340-8818
MFG
PADDOCK LABORATORIES INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 GRAMS GLUCOSE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE
TOTAL PRIMARY CONTAINER QUANTITY: 3
